Bank of New York Mellon’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.55M | Sell |
382,309
-37,184
| -9% | -$345K | ﹤0.01% | 2453 |
|
|
2025
Q1 | $3.07M | Sell |
419,493
-738
| -0.2% | -$5.41K | ﹤0.01% | 2450 |
|
|
2024
Q4 | $3.59M | Sell |
420,231
-4,204
| -1% | -$35.9K | ﹤0.01% | 2454 |
|
|
2024
Q3 | $3.69M | Sell |
424,435
-71,200
| -14% | -$619K | ﹤0.01% | 2443 |
|
|
2024
Q2 | $3.39M | Buy |
495,635
+164,383
| +50% | +$1.12M | ﹤0.01% | 2524 |
|
|
2024
Q1 | $3.01M | Buy |
331,252
+87,891
| +36% | +$800K | ﹤0.01% | 2550 |
|
|
2023
Q4 | $1.09M | Buy |
243,361
+3,051
| +1% | +$13.6K | ﹤0.01% | 3138 |
|
|
2023
Q3 | $755K | Sell |
240,310
-53,102
| -18% | -$167K | ﹤0.01% | 3333 |
|
|
2023
Q2 | $1.51M | Buy |
293,412
+3,357
| +1% | +$17.3K | ﹤0.01% | 2982 |
|
|
2023
Q1 | $1.53M | Buy |
290,055
+23,699
| +9% | +$125K | ﹤0.01% | 2942 |
|
|
2022
Q4 | $748K | Sell |
266,356
-4,254
| -2% | -$12K | ﹤0.01% | 3335 |
|
|
2022
Q3 | $1.12M | Buy |
270,610
+21,592
| +9% | +$89.6K | ﹤0.01% | 3146 |
|
|
2022
Q2 | $1M | Sell |
249,018
-14,022
| -5% | -$56.4K | ﹤0.01% | 3210 |
|
|
2022
Q1 | $1.3M | Buy |
263,040
+1,883
| +0.7% | +$9.32K | ﹤0.01% | 3147 |
|
|
2021
Q4 | $1.82M | Buy |
261,157
+14,820
| +6% | +$103K | ﹤0.01% | 3047 |
|
|
2021
Q3 | $2.46M | Buy |
246,337
+27,832
| +13% | +$278K | ﹤0.01% | 2861 |
|
|
2021
Q2 | $3.1M | Sell |
218,505
-39,412
| -15% | -$559K | ﹤0.01% | 2733 |
|
|
2021
Q1 | $4.23M | Sell |
257,917
-65,394
| -20% | -$1.07M | ﹤0.01% | 2517 |
|
|
2020
Q4 | $6.69M | Buy |
323,311
+135,811
| +72% | +$2.81M | ﹤0.01% | 2216 |
|
|
2020
Q3 | $1.43M | Buy |
187,500
+18,833
| +11% | +$143K | ﹤0.01% | 2890 |
|
|
2020
Q2 | $1.41M | Buy |
168,667
+45,335
| +37% | +$378K | ﹤0.01% | 2898 |
|
|
2020
Q1 | $610K | Buy |
123,332
+3,663
| +3% | +$18.1K | ﹤0.01% | 3255 |
|
|
2019
Q4 | $473K | Buy |
119,669
+7,397
| +7% | +$29.2K | ﹤0.01% | 3614 |
|
|
2019
Q3 | $341K | Buy |
112,272
+6,805
| +6% | +$20.7K | ﹤0.01% | 3725 |
|
|
2019
Q2 | $464K | Buy |
105,467
+2,990
| +3% | +$13.2K | ﹤0.01% | 3636 |
|
|
2019
Q1 | $407K | Buy |
102,477
+3,287
| +3% | +$13.1K | ﹤0.01% | 3629 |
|
|
2018
Q4 | $395K | Buy |
99,190
+4,896
| +5% | +$19.5K | ﹤0.01% | 3594 |
|
|
2018
Q3 | $649K | Hold |
94,294
| – | – | ﹤0.01% | 3505 |
|
|
2018
Q2 | $636K | Buy |
94,294
+11,276
| +14% | +$76.1K | ﹤0.01% | 3502 |
|
|
2018
Q1 | $541K | Buy |
83,018
+13,699
| +20% | +$89.3K | ﹤0.01% | 3547 |
|
|
2017
Q4 | $309K | Sell |
69,319
-12,267
| -15% | -$54.7K | ﹤0.01% | 3779 |
|
|
2017
Q3 | $504K | Buy |
81,586
+166
| +0.2% | +$1.03K | ﹤0.01% | 3581 |
|
|
2017
Q2 | $755K | Sell |
81,420
-7,316
| -8% | -$67.8K | ﹤0.01% | 3411 |
|
|
2017
Q1 | $824K | Buy |
88,736
+17,679
| +25% | +$164K | ﹤0.01% | 3340 |
|
|
2016
Q4 | $595K | Sell |
71,057
-13,142
| -16% | -$110K | ﹤0.01% | 3508 |
|
|
2016
Q3 | $578K | Buy |
84,199
+28,284
| +51% | +$194K | ﹤0.01% | 3462 |
|
|
2016
Q2 | $277K | Sell |
55,915
-4,832
| -8% | -$23.9K | ﹤0.01% | 3771 |
|
|
2016
Q1 | $586K | Sell |
60,747
-7,084
| -10% | -$68.3K | ﹤0.01% | 3359 |
|
|
2015
Q4 | $635K | Sell |
67,831
-4,893
| -7% | -$45.8K | ﹤0.01% | 3410 |
|
|
2015
Q3 | $1.02M | Buy |
72,724
+18,942
| +35% | +$266K | ﹤0.01% | 3154 |
|
|
2015
Q2 | $1.13M | Buy |
53,782
+32,006
| +147% | +$673K | ﹤0.01% | 3265 |
|
|
2015
Q1 | $914K | Buy |
21,776
+4,488
| +26% | +$188K | ﹤0.01% | 3352 |
|
|
2014
Q4 | $407K | Buy |
17,288
+4,309
| +33% | +$101K | ﹤0.01% | 3691 |
|
|
2014
Q3 | $195K | Buy |
+12,979
| New | +$195K | ﹤0.01% | 3897 |
|